In contrast, nerve growth factor was the only biomarker that showed a significant decrease in patients with peripheral neuropathy compared with controls (SMD, −1.38 [95% CI, −1.68 to −1.09]; P < .001; I2 = 98%), with considerable heterogeneity (Figure 3). Here, NGF is linked to peripheral neuropathy.